Article · 16 Feb 2026
Research articlePublished 2014
Supramolecular Facilities to Melanoma Cells B16F10 with Nanoparticles of a DEAE-Dextran-MMA Copolymer-Paclitaxel Complex
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
A DEAE-dextran-MMA copolymer (DDMC)–paclitaxel complex was generated using paclitaxel as the guest and DDMC as the host. The resulting nanoparticles were 200-300 nm in diameter and are thought to be useful as an anti-cancer drug delivery system because of forming a stable polymeric micelle in water. The resistance of B16F10 melanoma cells to paclitaxel was confirmed using survival curve analysis. On the other hand, there is no resistance of melanoma cells to DDMC–paclitaxel complex. The DDMC–paclitaxel complex showed superior anti-cancer activity to paclitaxel alone. The cell death rate was determined using Michaelis–Menten Equations, as the complex promoted allosteric supramolecular reaction to tubulin. From our results, the DDMC–paclitaxel complex was not extensively degraded in cells, and achieved good efficacy as an intact supramolecular anti-cancer agent. The DDMC–paclitaxel complex showed high reactivity and specificity of anti-melanoma cells, depending on its supramolecular facilities. The DDMC/PTX complex will be considered to be not degraded in cells, and represents the efficacy as supramolecular intact such as artificial enzymes having substrate-selective. It should be possible for other anti-cancer agents to offer the amplify effect from this supramolecular complex. These supramolecular facilities to melanoma cells will be very helpful to overcome cancer diseases.
Keywords
Subjects
NanotechnologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Nanomedicine & Nanotechnology.
Article · 21 Oct 2025
Green Synthesis of Chromium(III) Oxide Nanoparticles and their Evaluation against Skin Infections
Article · 19 Jun 2025
Potential of Bhasma as Nanomedicine for Disease Management: A Synopsis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nanomedicine & Nanotechnology
- SubjectNanotechnology
- BylineArticles whose byline prints “Yuki Eshita”
- BylineArticles whose byline prints “Rui-Cheng Ji”
- BylineArticles whose byline prints “Masayasu Onishi”
- BylineArticles whose byline prints “Masaaki Mizuno”
- BylineArticles whose byline prints “Jun Yoshida”
- BylineArticles whose byline prints “Naoji Kubota”
- BylineArticles whose byline prints “Yasuhiko Onishi”
